Welcome to our dedicated page for Chemed news (Ticker: CHE), a resource for investors and traders seeking the latest updates and insights on Chemed stock.
Chemed Corporation reports developments across two wholly owned subsidiaries: VITAS Healthcare, a provider of hospice and palliative end-of-life care, and Roto-Rooter, which provides plumbing, drain cleaning, water restoration and related services to residential and commercial customers.
Company news commonly covers quarterly operating results, VITAS patient revenue, admissions and census measures, Roto-Rooter service demand, franchise territory acquisitions, credit facility updates, share repurchases, new hospice-care locations and investor conference presentations.
Chemed Corporation (NYSE:CHE) has announced its participation in the upcoming RBC Global Healthcare Conference. The presentation is scheduled for Wednesday, May 21, 2025, at 9:30 a.m. (ET) at The InterContinental New York Barclay Hotel. Investors can access the audio webcast through Chemed's website, with replay available for 90 days after the presentation.
Chemed operates two major subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services in the United States.
Chemed Corporation (NYSE:CHE) has announced its participation in the Bank of America Securities 2025 Health Care Conference. The presentation is scheduled for Tuesday, May 13, 2025, at 3:40 PM (PDT) at the Encore at the Wynn Las Vegas. The event will be webcast live and accessible through Chemed's website, with presentation materials available at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours and accessible for 90 days.
Chemed operates two major subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services in the United States.
Chemed (NYSE: CHE) reported strong Q1 2025 financial results with consolidated revenue increasing 9.8% to $646.9 million. The company's GAAP Diluted EPS rose 14.6% to $4.86, while Adjusted Diluted EPS grew 8.3% to $5.63.
VITAS Healthcare, their end-of-life care segment, showed remarkable growth with net patient revenue up 15.1% to $407.4 million, driven by a 13.1% increase in Average Daily Census and 7.3% growth in admissions. The recently acquired Covenant Health assets contributed approximately $11.5-12.5 million in revenue.
Roto-Rooter, their plumbing and drain cleaning segment, reported more modest growth with revenue increasing 1.8% to $239.5 million. However, the segment experienced mixed results across services, with commercial revenue up 7.3% but declining metrics in residential drain cleaning and plumbing.
As of March 31, 2025, Chemed maintained a strong financial position with $173.9 million in cash and no debt, while repurchasing 50,000 shares for $29.8 million during the quarter.
Chemed (NYSE: CHE) has scheduled its first-quarter 2025 earnings release for April 23, 2025, after the NYSE trading closes. The company will host a conference call and webcast on April 24, 2025, at 10 a.m. ET to discuss quarterly results and provide a business update.
Participants can access the event through Chemed's investor relations website or via teleconference registration. A replay will be available approximately two hours after the call through the company's website.
Chemed operates two main subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services in the United States.
Chemed (NYSE:CHE) has announced its participation in the Oppenheimer 35th Annual Healthcare Conference scheduled for March 17, 2025, at 9:20 a.m. (ET). The presentation will be conducted virtually and will be accessible through a live webcast on the company's website at www.chemed.com.
The webcast replay will be available within 24 hours after the live presentation and remain accessible for 90 days. Headquartered in Cincinnati, Ohio, Chemed operates two major subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services in the United States.
Chemed (NYSE: CHE) reported its Q4 2024 financial results, showing mixed performance across its two main segments. Consolidated revenue increased 9.2% to $640.0 million, with GAAP EPS rising 2.0% to $6.02 and Adjusted EPS up 3.5% to $6.83.
VITAS Healthcare, their hospice care division, demonstrated strong growth with revenue increasing 17.4% to $411.0 million, driven by a 14.6% increase in Average Daily Census and a 3.5% rise in Medicare reimbursement rates. The segment completed an $85.0 million acquisition of Covenant Health's hospice assets in April 2024.
Roto-Rooter segment showed declining performance with revenue decreasing 2.9% to $229.0 million and Adjusted EBITDA falling 7.2% to $60.3 million. The company's 2025 guidance projects earnings per diluted share of $24.95 to $25.45, compared to $23.13 in 2024.
Chemed (NYSE:CHE) has declared a quarterly cash dividend of 50 cents per share, maintaining the same level as the previous quarter's payment. The dividend will be paid on March 14, 2025, to shareholders of record as of February 24, 2025.
This marks Chemed's 215th consecutive quarterly dividend in its 53-year history as a public company. The company operates through two wholly owned subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services in the United States.
Chemed (NYSE: CHE) has announced it will release its fourth-quarter 2024 financial results on February 26, 2025, after the NYSE trading close. The company will host a conference call and webcast on February 27, 2025, at 10 a.m. ET to discuss quarterly results and provide a business update.
Participants can access the event through Chemed's investor relations website or via teleconference registration. A replay will be available approximately two hours after the call through the company's website.
Chemed operates two main subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services in the United States.
Chemed (NYSE:CHE) has announced its participation in the 43rd Annual JPMorgan Healthcare Conference. The presentation is scheduled for Tuesday, January 14, 2024, at approximately 10:30 a.m. PST and will take place at the Westin St. Francis Hotel in San Francisco, CA.
The event will be accessible through a live webcast on Chemed's website (www.chemed.com) under the Investor Relations section. A replay of the webcast will be available approximately three hours after the live presentation and will remain accessible for 90 days.
Chemed , headquartered in Cincinnati, Ohio, operates two major subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the country's leading provider of plumbing and drain cleaning services.
Chemed (NYSE:CHE) has announced its participation in the BofA Securities 2024 Virtual Home Care Conference scheduled for Tuesday, December 10, 2024, at 1:20 PM (ET). The presentation will be available via live webcast through Chemed's website and will remain accessible for 90 days after the event.
Chemed operates through two main subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services in the United States. The company is headquartered in Cincinnati, Ohio, and is listed on the New York Stock Exchange.